PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
14-Feb-2024 Galderma Announces Regulatory Filing Acceptance for Nemolizumab in Prurigo Nodularis and Atopic Dermatitis in the U.S. and EU Businesswire
14-Feb-2024 Immunome Announces Pricing of Public Offering of Common Stock Businesswire
14-Feb-2024 Lost Money in Amylyx Pharmaceuticals, Inc.? Gibbs Law Group Investigates Potential Securities Law Violations Businesswire
14-Feb-2024 Treadwell Announces the Formation and Members of Scientific Advisory Board Businesswire
14-Feb-2024 MEI Pharma Reports Second Quarter Fiscal Year 2024 Results and Operational Highlights Businesswire
14-Feb-2024 Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of Amylyx Pharmaceuticals, Inc. (AMLX) Investors Businesswire
14-Feb-2024 Vistagen Reports Fiscal 2024 Third Quarter Financial Results and Provides Corporate Update Businesswire
14-Feb-2024 Electromed, Inc. Announces Record Financial Performance in Fiscal 2024 Second Quarter Businesswire
14-Feb-2024 Immunome Announces Proposed Public Offering of Common Stock Businesswire
14-Feb-2024 Ligand to Report Fourth Quarter and Full Year 2023 Financial Results on February 27, 2024 Businesswire
13-Feb-2024 Nature Made® Introduces Advanced Multivitamin Gummies with a Unique Combination of 20 Essential Nutrients to Help Consumers Get the Daily Nutritional Support They Need Businesswire
13-Feb-2024 Areteia Therapeutics kündigt weitere 75 Millionen US-Dollar in Serie A-Finanzierung für orales Dexpramipexol bei eosinophilem Asthma an Businesswire
13-Feb-2024 Areteia Therapeutics annonce un financement supplémentaire de série A de 75 millions USD pour le dexpramipexole oral dans la lutte contre l’asthme éosinophile Businesswire
13-Feb-2024 Number of Shares and Voting Rights of ADOCIA as of January 31st, 2024 Businesswire
13-Feb-2024 MyMD Pharmaceuticals Announces Reverse Stock Split to Maintain Nasdaq Listing Businesswire
13-Feb-2024 Global Molecular Diagnostics Market for Infectious Disease Analysis and Executive Guides 2023-2027: Assessing the Growing Demand for Rapid Diagnostic Solutions in Various Healthcare Settings - ResearchAndMarkets.com Businesswire
13-Feb-2024 Europe Cell-Based Assay Market Analysis and Forecast Report 2023-2032 Featuring Merck KGaA and Lonza Group with Focus on Emerging Technologies and Applications - ResearchAndMarkets.com Businesswire
13-Feb-2024 Zeda Announces Acquisition of The Orthopaedic Implant Company Businesswire
13-Feb-2024 Global and Regional High Performance Liquid Chromatography Market Analysis and Forecasts, 2024-2030: Examining the Diverse Applications from Pharmaceutical Development to Clinical Diagnostics - ResearchAndMarkets.com Businesswire
13-Feb-2024 Simulations Plus Launches Corporate Development Initiative Businesswire